問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
洪冠予
下載
2023-12-28 - 2029-12-31
Condition/Disease
Test Drug
Participate Sites6Sites
Recruiting6Sites
2024-10-03 - 2029-10-04
Participate Sites7Sites
Recruiting7Sites
2025-07-01 - 2030-10-31
Participate Sites5Sites
Recruiting5Sites
2024-03-15 - 2031-12-31
Participate Sites10Sites
Not yet recruiting1Sites
Recruiting9Sites
2024-07-01 - 2027-12-31
chronic kidney disease
placebo ‧ BI 690517 Empagliflozin
Participate Sites23Sites
Recruiting23Sites
全部
